Sino Medical Sciences Technology Inc., (SHA: 688108), a leading Chinese medical device company, has announced that it has received market approval for its HT Supreme drug-eluting stent system from the Ministry of Health in Turkey. This approval marks a significant expansion of the product’s reach and is set to benefit patients with local ischemic heart disease who require improved vascular stenosis symptoms.
Product Specifications and Applications
The HT Supreme drug-eluting stent system is designed for use in blood vessels with a diameter ranging from 2.25 to 4.00mm and is indicated for lesions up to 35mm in length. The stent system plays a crucial role in improving the symptoms of vascular stenosis in patients with local ischemic heart disease, offering a new treatment option in the Turkish market.
Global Recognition and Expansion
Developed based on Sino Med’s innovative “Healing window stage” theory, the HT Supreme drug-eluting stent system has already obtained marketing approvals in the European Union (EU), China, Thailand, Singapore, and Indonesia. This latest approval in Turkey further solidifies the product’s global standing and underscores Sino Medical Sciences Technology’s commitment to providing advanced medical solutions to a broader patient population.-Fineline Info & Tech
